The biotech company Stempeutics has received regulatory authorization to commence the first clinical trial ever to be conducted with human stem cells in India, for the use of adult stem cell therapy in the treatment of two different diseases.
Unburdened with a canine equivalent of the FDA, elderly dogs in Australia are learning how to be young again, thanks to adult stem cell therapy.
Opexa Therapeutics shows strong preclinical data for its autologous adult stem cell diabetes therapy.
Mothers of toddlers in England are being encouraged to store the baby teeth of their children as a future source of stem cells.
Humans are beginning to emulate salamanders in their regenerative abilities.
In FDA-approved clinical trials conducted in the U.S. with autologous adult stem cell therapy, heart patients show swift and significant improvement.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.
